Is hypofractionated whole pelvis radiotherapy (WPRT) as well tolerated as conventionally fractionated WPRT in prostate cancer patients? The HOPE trial

Is hypofractionated whole pelvis radiotherapy (WPRT) as well tolerated as conventionally fractionated WPRT in prostate cancer patients? The HOPE trial

Abstract Background Patients with high-risk prostate cancer are at increased risk of lymph node metastasis and are thought to benefit from whole pelvis radiotherapy (WPRT). There has been recent interest in the use of hypofractionated radiotherapy in treating prostate cancer. However, toxicity and c...

Full description

Bibliographic Details
Main Authors: Lucas C. Mendez, Andrew J. Arifin, Glenn S. Bauman, Vikram M. Velker, Belal Ahmad, Michael Lock, Varagur M. Venkatesan, Tracy L. Sexton, George B. Rodrigues, Jeff Chen, Bryan Schaly, Andrew Warner, David P. D’Souza
Format: Article
Language:English
Published: BMC 2020-10-01
Series:BMC Cancer
Subjects:
Prostate cancer
Brachytherapy
Radiotherapy
Pelvis
Hypofractionation
Toxicity
Online Access:http://link.springer.com/article/10.1186/s12885-020-07490-0

Internet

http://link.springer.com/article/10.1186/s12885-020-07490-0

Similar Items